TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SVA

Sinovac Biotech Ltd

Healthcare · Biotechnology

6.50$ +0.0% vs. previous close Closing price · As of: Sep 12, 2026

Statements

Income Statement

Sinovac Biotech Ltd (SVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 386 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SVA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
63 67 72 174 230 246 511 19,375 1,493 448 361 386
15 18 22 20 25 32 67 1,072 684 182 141 124
47 49 50 154 205 214 443 18,303 808 267 221 262
11 9.5 13 20 22 24 49 155 442 345 271 216
35 37 42 42 137 121 177 591 824 466 421 333
45 45 49 109 160 145 228 748 1,269 813 837 553
1.9 3.7 0.5 45 45 69 216 17,553 -466 -547 -475 -291
3.4 1.9 1.7 1.6 1.1 0.7 1.5 2.8 1.3 2.3 5.6 9.8
2.3 2.8 -0.4 45 47 71 217 17,563 25 -153 43 -262
2.1 3.0 2.7 8.3 10 5.6 31 3,104 -63 105 -63
-1.5 -1.4 -0.6 26 22 45 110 8,467 114 -100 91 -60
14 11 9.1 51 53 76 222 17,653 183 -6.0 -188

Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?